# Aspirin and Preeclampsia

Study · id `cardio:ct-nct04479072` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04479072](<https://clinicaltrials.gov/study/NCT04479072>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04479072

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.

## Technical summary

Registry record NCT04479072. Randomized; double masking; primary purpose prevention. Start 2021-02-15 (actual); primary completion 2026-12-01 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 180 participants (planned count; ClinicalTrials.gov record NCT04479072, source copy `cardio:ctgov-nct04479072-2026-05-04`, retrieved 2026-10-26)
- Started: 2021-02-15 (actual) (ClinicalTrials.gov record NCT04479072, source copy `cardio:ctgov-nct04479072-2026-05-04`, retrieved 2026-10-26)
- Primary completion: 2026-12-01 (anticipated) (ClinicalTrials.gov record NCT04479072, source copy `cardio:ctgov-nct04479072-2026-05-04`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT04479072, source copy `cardio:ctgov-nct04479072-2026-05-04`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT04479072, source copy `cardio:ctgov-nct04479072-2026-05-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04479072-2026-05-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: Aspirin and Preeclampsia
- Condition: Preeclampsia Postpartum
- Intervention (Drug): Aspirin 81 mg
- Intervention (Drug): Placebo
- Lead sponsor: University of Chicago
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record once doses, forms and salt words are removed: Aspirin (`core:aspirin`)
- Registry lists this organization as the lead sponsor: University of Chicago (`cardio:org-university-of-chicago`)

## Provenance

Content hash: b41435aa56ea6dd99a5cea02a18e2bff36783f7628322c933a7efdc33793afb4
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
